Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Subklewe

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Deutsche Medizinische Wochenschrift (1946)|June 18, 2010
[Hematology 2010]M Dreyling, M Subklewe, J Braess, et al.
Blood|November 14, 1997
A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cellsA Reddy, M Sapp, M Feldman, et al.
Chest|May 1, 1994
Expression of surface markers on alveolar macrophages from symptomatic patients with HIV infection as detected by flow cytometryK Wasserman, M Subklewe, G Pothoff, et al.
The Journal of Experimental Medicine|February 7, 2001
Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cellsM Subklewe, C Paludan, M L Tsang, et al.
Blood|August 10, 1999
Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virusM Subklewe, A Chahroudi, A Schmaljohn, et al.
European Journal of Immunology|December 22, 1999
Presentation of epstein-barr virus latency antigens to CD8(+), interferon-gamma-secreting, T lymphocytesM Subklewe, A Chahroudi, K Bickham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasionJ Engelmayer, M Larsson, M Subklewe, et al.
Leukemia|October 8, 2004
Extramedullary manifestation of a donor-derived acute myeloid leukemia in a liver transplant patientM Subklewe, M Nagy, C Schoch, et al.
The Journal of Experimental Medicine|May 17, 2000
Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1C Münz, K L Bickham, M Subklewe, et al.
Infection|December 22, 2025
Correction: Infections during AML induction chemotherapy in a contemporary cohort without fluoroquinolone prophylaxisS Ehrlich, J Eufinger, N Tahiri, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Deutsche Medizinische Wochenschrift (1946)|June 18, 2010
[Hematology 2010]M Dreyling, M Subklewe, J Braess, et al.
Blood|November 14, 1997
A monocyte conditioned medium is more effective than defined cytokines in mediating the terminal maturation of human dendritic cellsA Reddy, M Sapp, M Feldman, et al.
Chest|May 1, 1994
Expression of surface markers on alveolar macrophages from symptomatic patients with HIV infection as detected by flow cytometryK Wasserman, M Subklewe, G Pothoff, et al.
The Journal of Experimental Medicine|February 7, 2001
Dendritic cells cross-present latency gene products from Epstein-Barr virus-transformed B cells and expand tumor-reactive CD8(+) killer T cellsM Subklewe, C Paludan, M L Tsang, et al.
Blood|August 10, 1999
Induction of Epstein-Barr virus-specific cytotoxic T-lymphocyte responses using dendritic cells pulsed with EBNA-3A peptides or UV-inactivated, recombinant EBNA-3A vaccinia virusM Subklewe, A Chahroudi, A Schmaljohn, et al.
European Journal of Immunology|December 22, 1999
Presentation of epstein-barr virus latency antigens to CD8(+), interferon-gamma-secreting, T lymphocytesM Subklewe, A Chahroudi, K Bickham, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 10, 1999
Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasionJ Engelmayer, M Larsson, M Subklewe, et al.
Leukemia|October 8, 2004
Extramedullary manifestation of a donor-derived acute myeloid leukemia in a liver transplant patientM Subklewe, M Nagy, C Schoch, et al.
The Journal of Experimental Medicine|May 17, 2000
Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1C Münz, K L Bickham, M Subklewe, et al.
Infection|December 22, 2025
Correction: Infections during AML induction chemotherapy in a contemporary cohort without fluoroquinolone prophylaxisS Ehrlich, J Eufinger, N Tahiri, et al.
Pageof 3